Although the molecular mechanism underlying SAP30 upregulation in breast tumors remains to be determined, our findings reveal that SAP30 is an independent prognostic factor for breast cancer and has a strong clinical relevance in patients with breast cancer. This evidence concerns the gene SAP30 and breast neoplasm.